This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nussberger, J. Articles by Brunner, H. R. Search for Related Content PubMed PubMed Citation Articles by Nussberger, J. Articles by Brunner, H. R.

Hypertension, Vol 8, 476-482, Copyright © 1986 by American Heart Association

ARTICLES

Specific measurement of angiotensin metabolites and in vitro generated angiotensin II in plasma

J Nussberger, DB Brunner, B Waeber and HR Brunner

Combining high-performance liquid chromatography with radioimmunoassay enabled the precise measurement of different angiotensins and their metabolites in plasma. Peptides were extracted from 2 ml of plasma by reversible adsorption to phenylsilyl-silica, separated by isocratic high-performance liquid chromatography, and quantitated by radioimmunoassay using a sensitive but suitably cross-reacting angiotensin II antiserum. For the C-terminal angiotensin II metabolites (2-8)heptapeptide, (3-8)hexapeptide, and (4-8)pentapeptide, overall recoveries of 10 fmol peptide added to 1 ml of plasma were (mean +/- SD), 74 +/- 6, 68 +/- 8, and 67 +/- 11%, respectively. The detection limit for these peptides in plasma was 0.2 fmol/ml. Blanks were below the detection limits. In eight seated normal subjects treated for 4 days with enalapril, 20 mg p.o., q.d., angiotensin II metabolites tended to decrease during the 4 postdrug hours. However, their cumulated concentration in relation to octapeptide increased from 54 to 163% on Day 1 and from 62 to 103% on Day 4. After 4 hours of converting enzyme inhibition with enalapril there was still a close correlation between plasma renin activity and angiotensin-(1-8)octapeptide level (r = 0.83, p less than 0.05) and between blood angiotensin I and angiotensin-(1-8)octapeptide levels (r = 0.86, p less than 0.01). Adding angiotensin I in vitro raised the angiotensin-(1-8)octapeptide levels after incubation at 4 degrees C for 4 hours. Thus, immunoreactive "angiotensin II" does not disappear after converting enzyme inhibition largely because of the cumulated contribution of cross-reacting metabolites and partly because of in vitro generation of true angiotensin II.

This article has been cited by other articles:

				N. D.L. Fisher, A.H. Jan Danser, J. Nussberger, W. P. Dole, and N. K. Hollenberg Renal and Hormonal Responses to Direct Renin Inhibition With Aliskiren in Healthy Humans Circulation, June 24, 2008; 117(25): 3199 - 3205. [Abstract] [Full Text] [PDF]

				J. E. Jalil, A. Perez, M. P. Ocaranza, J. Bargetto, A. Galaz, and S. Lavandero Increased Aortic NADPH Oxidase Activity in Rats With Genetically High Angiotensin-Converting Enzyme Levels Hypertension, December 1, 2005; 46(6): 1362 - 1367. [Abstract] [Full Text] [PDF]

				M. P. Ocaranza, G. Diaz-Araya, J. E. Carreno, D. Munoz, J. P. Riveros, J. E. Jalil, and S. Lavandero Polymorphism in gene coding for ACE determines different development of myocardial fibrosis in rats Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H498 - H506. [Abstract] [Full Text] [PDF]

				M. Boschmann, J. Jordan, F. Adams, N.-J. Christensen, J. Tank, G. Franke, M. Stoffels, A. M. Sharma, F. C. Luft, and S. Klaus Tissue-Specific Response to Interstitial Angiotensin II in Humans Hypertension, January 1, 2003; 41(1): 37 - 41. [Abstract] [Full Text] [PDF]

				C. Ingert, M. Grima, C. Coquard, M. Barthelmebs, and J.-L. Imbs Effects of dietary salt changes on renal renin-angiotensin system in rats Am J Physiol Renal Physiol, November 1, 2002; 283(5): F995 - F1002. [Abstract] [Full Text] [PDF]

				C. Ingert, M. Grima, C. Coquard, M. Barthelmebs, and J.-L. Imbs Contribution of angiotensin II internalization to intrarenal angiotensin II levels in rats Am J Physiol Renal Physiol, November 1, 2002; 283(5): F1003 - F1010. [Abstract] [Full Text] [PDF]

				J. Nussberger, D. B. Brunner, J. A. Nyfeler, L. Linder, and H. R. Brunner Measurement of Immunoreactive Angiotensin-(1-7) Heptapeptide in Human Blood Clin. Chem., April 1, 2001; 47(4): 726 - 729. [Abstract] [Full Text] [PDF]

				A.H.J. Danser, J. J Saris, M. P Schuijt, and J. P van Kats Is there a local renin--angiotensin system in the heart? Cardiovasc Res, November 1, 1999; 44(2): 252 - 265. [Abstract] [Full Text] [PDF]

				A. MaassenVanDenBrink, R. de Vries, P. R. Saxena, M. A.D.H. Schalekamp, and A.H.J. Danser Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase Cardiovasc Res, November 1, 1999; 44(2): 407 - 415. [Abstract] [Full Text] [PDF]

				C. A.M van Kesteren, J. J Saris, D. H.W Dekkers, J. M.J Lamers, P. R Saxena, M. A.D.H Schalekamp, and A.H.J. Danser Cultured neonatal rat cardiac myocytes and fibroblasts do not synthesize renin or angiotensinogen: evidence for stretch-induced cardiomyocyte hypertrophy independent of angiotensin II Cardiovasc Res, July 1, 1999; 43(1): 148 - 156. [Abstract] [Full Text] [PDF]

				P Di Pasquale, V Bucca, S Scalzo, S Cannizzaro, A Giubilato, and S Paterna Does the addition of losartan improve the beneficial effects of ACE inhibitors in patients with anterior myocardial infarction? A pilot study Heart, June 1, 1999; 81(6): 606 - 611. [Abstract] [Full Text]

				A. Virdis, L. Ghiadoni, M. Marzilli, E. Orsini, S. Favilla, P. Duranti, S. Taddei, P. Marraccini, and A. Salvetti Adenosine causes the release of active renin and angiotensin II in the coronary circulation of patients with essential hypertension J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1677 - 1684. [Abstract] [Full Text] [PDF]

				H. Nishimura, H. Buikema, O. Baltatu, D. Ganten, and H. Urata Functional evidence for alternative ANG II-forming pathways in hamster cardiovascular system Am J Physiol Heart Circ Physiol, October 1, 1998; 275(4): H1307 - H1312. [Abstract] [Full Text] [PDF]

				F. Broughton Pipkin and P. N. Baker Angiotensin II Has Depressor Effects in Pregnant and Nonpregnant Women Hypertension, November 1, 1997; 30(5): 1247 - 1252. [Abstract] [Full Text]

				A. Wolny, J.-P. Clozel, J. Rein, P. Mory, P. Vogt, M. Turino, W. Kiowski, and W. Fischli Functional and Biochemical Analysis of Angiotensin II–Forming Pathways in the Human Heart Circ. Res., February 1, 1997; 80(2): 219 - 227. [Abstract] [Full Text]

				M. R. Goldberg, T. E. Bradstreet, E. J. McWilliams, W. K. Tanaka, S. Lipert, T. D. Bjornsson, S. A. Waldman, B. Osborne, L. Pivadori, G. Lewis, et al. Biochemical Effects of Losartan, a Nonpeptide Angiotensin II Receptor Antagonist, on the Renin-Angiotensin-Aldosterone System in Hypertensive Patients Hypertension, January 1, 1995; 25(1): 37 - 46. [Abstract] [Full Text]